Prem S. Shah - Aug 31, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Aug 31, 2023
Transactions value $
-$228,616
Form type
4
Date filed
9/1/2023, 04:24 PM
Previous filing
Apr 4, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$229K -3.51K -6.44% $65.17 51K Aug 31, 2023 Direct F1
holding CVS Common Stock (Restricted) 29.6K Aug 31, 2023 Direct
holding CVS ESOP Common Stock 4.67K Aug 31, 2023 Direct
holding CVS Stock Unit (deferred) 7.87K Aug 31, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 12.2K Aug 31, 2023 Common Stock 12.2K $1.00 Direct F3, F4
holding CVS Stock Option 2.94K Aug 31, 2023 Common Stock 2.94K $104.82 Direct F5
holding CVS Stock Option 846 Aug 31, 2023 Common Stock 846 $62.21 Direct F6
holding CVS Stock Option 9.47K Aug 31, 2023 Common Stock 9.47K $54.19 Direct F7
holding CVS Stock Option 28.6K Aug 31, 2023 Common Stock 28.6K $58.34 Direct F8
holding CVS Stock Option 26.6K Aug 31, 2023 Common Stock 26.6K $75.24 Direct F9
holding CVS Stock Option 28.7K Aug 31, 2023 Common Stock 28.7K $74.30 Direct F10
holding CVS Stock Option 41.6K Aug 31, 2023 Common Stock 41.6K $101.09 Direct F11
holding CVS Stock Option 89.1K Aug 31, 2023 Common Stock 89.1K $74.31 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
F2 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5 Option became exercisable in four equal installments commencing 04/01/2017.
F6 Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F7 Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
F8 Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F9 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
F10 Option became exercisable in three equal installments commencing 04/01/2022.
F11 Option became exercisable in four equal installments, commencing 4/1/2023.
F12 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.